Yüklüyor......
Whither radioimmunotherapy: To be or not to be?
Therapy of cancer with radiolabeled monoclonal antibodies has produced impressive results in preclinical experiments and in clinical trials conducted in radiosensitive malignancies, particularly B cell lymphomas. Two “first generation”, directly radiolabeled anti-CD20 antibodies, (131)Iodine-tositum...
Kaydedildi:
| Yayımlandı: | Cancer Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5413412/ https://ncbi.nlm.nih.gov/pubmed/28428282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-2523 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|